Following the success of recombinant somatostatin, Genentech and Eli Lilly pioneered the development of the first recombinant human insulin
Manufacturing deficiencies: Some pharmacies received warning letters for manufacturing practices that did not meet applicable standards, including inadequate sterility assurance, deficient testing, and improper facility conditions
NG, AT, and MB were involved in the critical revision and writing of the manuscript
Montandon SA, Jornayvaz FR (2017) Effects of Antidiabetic Drugs on Gut Microbiota Composition
Impact of viral-mediated IGF-I gene transfer on skeletal muscle following cast immobilization
Compounded semaglutide from PlexusDx licensed 503A pharmacies follows the same stability and storage standards as branded products